1. Home
  2. TENX vs OCG Comparison

TENX vs OCG Comparison

Compare TENX & OCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • OCG
  • Stock Information
  • Founded
  • TENX 1967
  • OCG 2018
  • Country
  • TENX United States
  • OCG Hong Kong
  • Employees
  • TENX N/A
  • OCG N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • OCG Other Consumer Services
  • Sector
  • TENX Health Care
  • OCG Consumer Discretionary
  • Exchange
  • TENX Nasdaq
  • OCG Nasdaq
  • Market Cap
  • TENX 21.6M
  • OCG 66.1M
  • IPO Year
  • TENX N/A
  • OCG 2020
  • Fundamental
  • Price
  • TENX $5.82
  • OCG $6.59
  • Analyst Decision
  • TENX Strong Buy
  • OCG
  • Analyst Count
  • TENX 3
  • OCG 0
  • Target Price
  • TENX $16.00
  • OCG N/A
  • AVG Volume (30 Days)
  • TENX 13.0K
  • OCG 38.8K
  • Earning Date
  • TENX 05-20-2025
  • OCG 05-13-2025
  • Dividend Yield
  • TENX N/A
  • OCG N/A
  • EPS Growth
  • TENX N/A
  • OCG N/A
  • EPS
  • TENX N/A
  • OCG N/A
  • Revenue
  • TENX N/A
  • OCG $1,227,855.00
  • Revenue This Year
  • TENX N/A
  • OCG N/A
  • Revenue Next Year
  • TENX N/A
  • OCG N/A
  • P/E Ratio
  • TENX N/A
  • OCG N/A
  • Revenue Growth
  • TENX N/A
  • OCG N/A
  • 52 Week Low
  • TENX $2.77
  • OCG $0.91
  • 52 Week High
  • TENX $7.89
  • OCG $7.47
  • Technical
  • Relative Strength Index (RSI)
  • TENX 52.41
  • OCG 84.61
  • Support Level
  • TENX $5.34
  • OCG $3.84
  • Resistance Level
  • TENX $5.87
  • OCG $7.47
  • Average True Range (ATR)
  • TENX 0.34
  • OCG 0.59
  • MACD
  • TENX 0.04
  • OCG 0.19
  • Stochastic Oscillator
  • TENX 86.99
  • OCG 77.59

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About OCG Oriental Culture Holding LTD

Oriental Culture Holding Ltd is an online provider of collectibles and artwork e-commerce services. The company also offers online and offline integrated marketing, storage, and technical maintenance service to customers in China and Hong Kong. It operates through one segment namely, e-commerce of artwork trading. It generates revenue through listing service fees, transaction fees, and other revenues collected from traders.

Share on Social Networks: